Geffen Residence & Renewal Ltd (TLV:GEFR)
Israel · Delayed Price · Currency is ILS · Price in ILA 81.20
0.00 (0.00%)
At close: Aug 18, 2026
TLV:GEFR Market Cap
TLV:GEFR has a market cap or net worth of 333.63 million as of August 19, 2026. Its market cap has increased by 88.14% in one year.
Market Cap
333.63M
Enterprise Value
359.89M
Revenue
79.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
81.20
ChartMarket Cap Chart
Since December 20, 2018, TLV:GEFR's market cap has increased from 29.33M to 333.63M, an increase of 1,037.63%. That is a compound annual growth rate of 37.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 333.63M | 26.86% |
| Dec 31, 2025 | 263.00M | 76.79% |
| Dec 31, 2024 | 148.76M | 47.72% |
| Dec 31, 2023 | 100.70M | 61.09% |
| Dec 29, 2022 | 62.51M | 89.46% |
| Dec 30, 2021 | 33.00M | -64.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 248.81M |
| Matricelf | 77.03M |
| Clal Biotechnology Industries | 37.49M |
| BioLineRx | 36.69M |
| BioLight Life Sciences | 27.58M |
| Can-Fite BioPharma | 22.76M |
| XTL Biopharmaceuticals | 18.68M |
| Purple Biotech | 18.65M |